These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19433730)

  • 1. Methodologic aspects of glaucoma phamacogenomic studies.
    Leffler CT
    Arch Ophthalmol; 2009 May; 127(5):706; author reply 706-7. PubMed ID: 19433730
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraocular pressure response to topical beta-blockers associated with an ADRB2 single-nucleotide polymorphism.
    McCarty CA; Burmester JK; Mukesh BN; Patchett RB; Wilke RA
    Arch Ophthalmol; 2008 Jul; 126(7):959-63. PubMed ID: 18625943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of adult glaucoma.
    Challa P
    Int Ophthalmol Clin; 2011; 51(3):37-51. PubMed ID: 21633237
    [No Abstract]   [Full Text] [Related]  

  • 4. The GLC1H glaucoma locus may reflect glaucoma with elevated intraocular pressure.
    Duggal P; Klein AP; Lee KE; Klein R; Klein BE; Bailey-Wilson JE
    Arch Ophthalmol; 2007 Dec; 125(12):1716-7; author reply 1717. PubMed ID: 18071131
    [No Abstract]   [Full Text] [Related]  

  • 5. Complex genetics of glaucoma susceptibility.
    Libby RT; Gould DB; Anderson MG; John SW
    Annu Rev Genomics Hum Genet; 2005; 6():15-44. PubMed ID: 16124852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glaucoma genetics: the light at the end of the tunnel fourteen years later].
    Escribano J
    Arch Soc Esp Oftalmol; 2010 Nov; 85(11):353-4. PubMed ID: 21277460
    [No Abstract]   [Full Text] [Related]  

  • 7. SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open angle glaucoma patients.
    Fan BJ; Wang DY; Fan DS; Tam PO; Lam DS; Tham CC; Lam CY; Lau TC; Pang CP
    Mol Vis; 2005 Aug; 11():625-31. PubMed ID: 16148883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of old and new genes for open-angle glaucoma.
    Ramdas WD; van Koolwijk LM; Cree AJ; Janssens AC; Amin N; de Jong PT; Wolfs RC; Gibson J; Kirwan JF; Hofman A; Rivadeneira F; Oostra BA; Uitterlinden AG; Ennis S; Lotery AJ; Lemij HG; Klaver CC; Vingerling JR; Jansonius NM; van Duijn CM
    Ophthalmology; 2011 Dec; 118(12):2389-97. PubMed ID: 21872936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of primary glaucoma.
    Khan AO
    Curr Opin Ophthalmol; 2011 Sep; 22(5):347-55. PubMed ID: 21730848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphisms of myocilin and optineurin in primary open angle glaucoma patients].
    Yao HY; Cheng CY; Fan BJ; Tam OS; Tham CY; Wang DY; Lam SC; Pang CP
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):554-9. PubMed ID: 16681888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of genome research on open-angle glaucoma in Finland].
    Forsman E; Lemmelä S; Puska P; Järvelä I
    Duodecim; 2011; 127(14):1426-31. PubMed ID: 21888043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucoma genetics.
    Challa P
    Int Ophthalmol Clin; 2008; 48(4):73-94. PubMed ID: 18936638
    [No Abstract]   [Full Text] [Related]  

  • 13. The genetics of intraocular pressure.
    Ojha P; Wiggs JL; Pasquale LR
    Semin Ophthalmol; 2013; 28(5-6):301-5. PubMed ID: 24138038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocilin mt.1 gene promoter single nucleotide polymorphism (-1000C>G) in Brazilian patients with primary open angle glaucoma.
    Kasahara N; Caixeta-Umbelino C; Paolera MD; Rocha MN; Richeti F; Vasconcellos JP; Cohen R; Costa VP; Longui CA; Melo MR; Melo MB
    Ophthalmic Genet; 2011 Mar; 32(1):18-23. PubMed ID: 21174523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
    Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
    Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
    Good CB
    Pharmacoepidemiol Drug Saf; 2001; 10(6):509-10. PubMed ID: 11828832
    [No Abstract]   [Full Text] [Related]  

  • 17. New direction for glaucoma therapeutics: focus on the olfactomedin domain of myocilin.
    Donegan RK; Lieberman RL
    Future Med Chem; 2012 Nov; 4(17):2131-4. PubMed ID: 23190098
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mutations and polymorphisms in the genes for myocilin and optineur in as the risk factors of primary open-angle glaucoma].
    Rakhmanov VV; Nikitina NIa; Zakharova FM; Astakhov IuS; Kvasova MD; Vasil'ev VB; Golubkov VI; Mandel'shtam MIu
    Genetika; 2005 Nov; 41(11):1567-74. PubMed ID: 16358725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From gene to disease; primary open-angle glaucoma and three known genes: MYOC, CYP1B1 and OPTN].
    Bergen AA; Leschot NJ; Hulsman CA; De Smet MD; De Jong PT
    Ned Tijdschr Geneeskd; 2004 Jul; 148(27):1343-4. PubMed ID: 15283026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of the disease phenotype of myocilin-causing glaucoma by a natural osmolyte.
    Jia LY; Gong B; Pang CP; Huang Y; Lam DS; Wang N; Yam GH
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3743-9. PubMed ID: 19234343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.